1221278-28-9

Basic information

• Product Name: C₅H₇N₃S
• Synonyms: C₅H₇N₃S
• CAS NO: 1221278-28-9
• Molecular Weight: 141.197
• Mol File: 1221278-28-9.mol
• Article Data: 1

Chemical Properties

• Boiling Point: 290.8±32.0 °C(Predicted)
• Density: 1.35±0.1 g/cm3(Predicted)
• CAS DataBase Reference: C₅H₇N₃S(CAS DataBase Reference)
• NIST Chemistry Reference: C₅H₇N₃S(1221278-28-9)
• EPA Substance Registry System: C₅H₇N₃S(1221278-28-9)

Safety Data

• Hazardous Substances Data: 1221278-28-9(Hazardous Substances Data)

Usage

General Description

The chemical C5H7N3S, also known as 2-Acetylthiazole, is a heterocyclic compound that contains carbon, hydrogen, nitrogen, and sulfur atoms. It is commonly used as a flavoring agent and fragrance in the food and fragrance industries due to its distinctive thiazole aroma. 2-Acetylthiazole is often found in various food products, such as baked goods, dairy products, and beverages, to enhance their flavors. In addition to its use in the food industry, this compound is also utilized in the production of perfumes and cosmetics. Its unique aroma and chemical properties make it a valuable ingredient in a wide range of consumer products.

Upstream product

• 17827-61-1 methyl ester of 1-methylpyrazole-3-carboxylic acid 

Downstream Products

• 1322586-63-9 DB₁₈₅₆ 

Relevant articles and documents

ANNELATED PYRROLES AND THEIR USE AS CRAC INHIBITORS

The invention relates to substituted bicyclic pyrroloheterocyclyl compounds of general formula (I), wherein A1 and A2 represent direct bond or C(=O), with the proviso that 0 or 1 of A1 and A2 represents C(=O); m and n independently denote 0, 1, 2 or 3, with the proviso that the sum [n + m] is 1, 2, 3 or 4; R1 denotes H, F, CI, Br, I, CN, CF3, CF2H, CFH2, CO2H, CO2R13, R13, OH. O-R13, NH2, N(H)R13, N(R13)2, R2 represents 0 to 4 substituents, each independently selected from F, CI, Br, CN. CF3, CF2H, CFH2, R13, OH, O-R13, NH2, N(H)R13 and N(R13)2; Ar1 represents phenyl or 5- or 6-membered heteroaryl, in each case unsubstituted or substituted with one, two, three or four substituents, independently selected from F, CI, Br, CN, CF3. CF2H, CFH2, R13 and O- R13; or C3-6-cycloalkyl or 3 to 7 membered heterocycloalkyl, in each case unsubstituted or mono- or polysubstituted; Ar2 represents phenyl or 5- or 6-membered heteroaryl, wherein said phenyl or said heteroaryl may be unsubstituted or mono- or polysubstituted and may be condensed with a 4-, 5-, 6-or 7- membered ring, being carbocyclic or heterocyclic, wherein said condensed ring may be saturated, partially unsaturated or aromatic and may be unsubstituted or mono- or polysubstituted; useful as ICRAC inhibitors, to pharmaceutical compositions containing these compounds and to these compounds for the use in the treatment and/or prophylaxis of diseases and/or disorders, in particular inflammatory diseases and/or inflammatory disorders.